Fairfax Identity Laboratories/Commonwealth Biotechnologies

Established in 1992, CBI is among the most comprehensive CROs in existence, offering Concept to Clinic fundamental technologies applicable to state-of-the-art Life Sciences investigations. Visit CBI on the web at www.cbi-biotech.com for a full listing of our capabilities.

Fairfax Identity Laboratories, a member of the CBI group of companies, has developed a Clinical Genetics Division to support a wide range of Clinical Trials. Our Clinical Genetics Division is CLIA-certified and GLP compliant to assist you at any stage of your clinical trial. From pre-clinical studies to validation of your method to Phase III-IV testing, FIL can support your investigational new drug (IND) submission to the FDA and perform the genetic analysis necessary to move your product forward.

FIL supports a wide variety of clinical trials, performing services from mutation detection in blood samples to comparative microsatellite analysis of patient samples. Our clients include researchers from government, academic, and the pharmaceutical industry. FIL is CLIA certified and GLP compliant to assist in the generation of data for an investigational new drug (IND) submission to the FDA.

• Custom Assay Development
• Mutation detection by capillary electrophoresis
• Single nucleotide polymorphism (SNP) validation
• Short Tandem Repeat (STR) (microsatellite) analysis
• Quantitative (real-time) PCR analysis
• DNA sequencing: normal vs tumor tissue
• Mitochondrial DNA (mtDNA) sequencing and/or SNP analysis
• Genotyping by capillary electrophoresis
•  





 

Any sample type is acceptable: blood, buccal swabs, urine, cerebrospinal fluid, saliva.

FIL offers additional services to facilitate clinical trial sample collection and testing:

• FIL will provide kits for sample collection
• FIL tracks all of its samples using an electronic LIMS database

The NIH has recently recommended that cell lines used in research undergo authentication to verify their identity (NIH Notice Number OT-OD-08-17) and stated that "(g)rant applications that fail to employ such practices would not be considered of the highest quality and such manuscripts would not fare well in the journal review process."

 

Human Cell lines
FIL uses the 13 core STR loci that comprise the Combined DNA Index System (CODIS) convicted offender database to identify human-derived cell banks. These are the same loci used by ATCC to test their cell lines.

Fairfax Identity Laboratories (FIL) has developed a proprietary panel of DNA-based tests that can identify and quantify the eight known human herpes viruses in the blood. The panel is variant-specific and can therefore detect each subtype even in the presence of other, closely related members of the family. For more information, please see our website at www.herpes-testing.com

Contact Information

Fairfax Identity Laboratories/Commonwealth Biotechnologies
Sarah Helber, PhD, Group Leader, Clinical Genetics
601 Biotech Dr.
Richmond, VA 23235 USA
Phone: 800-735-9224
Fax: 804-648-2641
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.